Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Permit To Import Controlled Substances for Domestic and/or Scientific Purposes; DEA Form 357, 34237-34238 [2020-11923]
Download as PDF
<![CDATA[
lotter on DSK9F5VC42PROD with NOTICES
Federal Register / Vol. 85, No. 107 / Wednesday, June 3, 2020 / Notices
A Federal Register notice with a 60day public comment period soliciting
comments on this collection of
information was published on March
10, 2020 (85 FR 13922). No comments
were received.
As part of our continuing effort to
reduce paperwork and respondent
burdens, we are again soliciting
comments from the public and other
Federal agencies on the proposed ICR
that is described below. We are
especially interested in public comment
addressing the following:
(1) Whether or not the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether or not the
information will have practical utility;
(2) The accuracy of our estimate of the
burden for this collection of
information, including the validity of
the methodology and assumptions used;
(3) Ways to enhance the quality,
utility, and clarity of the information to
be collected; and
(4) How might the agency minimize
the burden of the collection of
information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of response.
Comments that you submit in
response to this notice are a matter of
public record. Before including your
address, phone number, email address,
or other personal identifying
information in your comment, you
should be aware that your entire
comment—including your personal
identifying information—may be made
publicly available at any time. While
you can ask us in your comment to
withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Abstract: This series of surveys is
needed to ensure that technical
assistance activities, technology transfer
activities and technical forums are
useful for those who participate or
receive the assistance. Specifically,
representatives from State and Tribal
regulatory and reclamation authorities,
representatives of industry,
environmental or citizen groups, or the
public, are the recipients of the
assistance or participants in these
forums. These surveys will be the
primary means through which OSMRE
evaluates its performance in meeting the
performance goals outlined in its annual
plans developed pursuant to the
Government Performance and Results
Act.
VerDate Sep<11>2014
18:35 Jun 02, 2020
Jkt 250001
Title of Collection: Technical
Evaluation Surveys.
OMB Control Number: 1029–0114.
Form Number: None.
Type of Review: Extension of a
currently approved collection.
Respondents/Affected Public:
Individuals who request information or
assistance, although generally States
and Tribal employees.
Total Estimated Number of Annual
Respondents: 222.
Total Estimated Number of Annual
Responses: 222.
Estimated Completion Time per
Response: 5 minutes.
Total Estimated Number of Annual
Burden Hours: 19 hours.
Respondent’s Obligation: Required to
obtain or retain a benefit.
Frequency of Collection: Annually.
Total Estimated Annual Nonhour
Burden Cost: None.
An agency may not conduct or
sponsor and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number.
The authority for this action is the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
Mark J. Gehlhar,
Information Collection Clearance Officer,
Division of Regulatory Support.
[FR Doc. 2020–11958 Filed 6–2–20; 8:45 am]
BILLING CODE 4310–05–P
INTERNATIONAL TRADE
COMMISSION
34237
FR 49763, September 23, 2019). Notice
of the scheduling of the Commission’s
review and of a public hearing to be
held in connection therewith was given
by posting copies of the notice in the
Office of the Secretary, U.S.
International Trade Commission,
Washington, DC, and by publishing the
notice in the Federal Register on
December 10, 2019 (84 FR 67475). In
light of the restrictions on access to the
Commission building due to the
COVID–19 pandemic, and in accordance
with 19 U.S.C. 1677c(a)(1), the
Commission did not cancel its hearing
scheduled for March 31, 2020, but
conducted its hearing through a series of
written questions, submissions of
written testimony, written responses to
questions, posthearing briefs, and
closing statements presented via video
and teleconference; all persons who
requested the opportunity were
permitted to participate.
The Commission made this
determination pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determination in
this review on May 28, 2020. The views
of the Commission are contained in
USITC Publication 5058 (May 2020),
entitled Silicon Metal from Russia:
Investigation No. 731–TA–991 (Third
Review).
By order of the Commission.
Issued: May 28, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–11914 Filed 6–2–20; 8:45 am]
BILLING CODE 7020–02–P
[Investigation No. 731–TA–991 (Third
Review)]
DEPARTMENT OF JUSTICE
Silicon Metal From Russia
Determination
[OMB Number 1117–0013]
On the basis of the record 1 developed
in the subject five-year review, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
antidumping duty order on silicon
metal from Russia would be likely to
lead to continuation or recurrence of
material injury to an industry in the
United States within a reasonably
foreseeable time.
Background
The Commission instituted this
review on June 3, 2019 (84 FR 25561)
and determined on September 6, 2019
that it would conduct a full review (84
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Application for
Permit To Import Controlled
Substances for Domestic and/or
Scientific Purposes; DEA Form 357
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
SUMMARY:
E:\FR\FM\03JNN1.SGM
03JNN1
34238
Federal Register / Vol. 85, No. 107 / Wednesday, June 3, 2020 / Notices
Comments are encouraged and
will be accepted for 60 days until
August 3, 2020.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Scott A. Brinks, Regulatory Drafting and
Policy Support Section, Drug
Enforcement Administration; Mailing
Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone:
(571) 362–3261.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
DATES:
lotter on DSK9F5VC42PROD with NOTICES
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Application for Permit to Import
Controlled Substances for Domestic
and/or Scientific Purposes Pursuant to
21 U.S.C. 952.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Form: 357. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
VerDate Sep<11>2014
18:35 Jun 02, 2020
Jkt 250001
Affected public (Primary): Business or
other for-profit.
Affected public (Other): None.
Abstract: Section 1002 of the
Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 952) and
Title 21, Code of Federal Regulations
(21 CFR), Sections 1312.11, 1312.12 and
1312.13 requires any person who
desires to import controlled substances
listed in schedules I or II, any narcotic
substance listed in schedules III or IV,
or any non-narcotic substance in
schedule III which the Administrator
has specifically designated by regulation
in § 1312.30, or any nonnarcotic
substance in schedule IV or V which is
also listed in schedule I or II of the
Convention on Psychotropic
Substances, must have an import
permit. To obtain the permit to import
controlled substances for domestic and
or scientific purposes, an application for
the permit must be made to DEA on
DEA Form 357.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that 171
registrants participate in this
information collection, taking an
estimated 0.26 hours per registrant
annually.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: DEA estimates the
total public burden (in hours) associated
with this collection: 497 annual burden
hours.
If additional information is required
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: May 28, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2020–11923 Filed 6–2–20; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
[OMB Number 1117–0024]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Report of Loss
or Disappearance of Listed Chemicals
and Regulated Transactions in
Tableting/Encapsulating Machines;
DEA Forms 107, 452
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 3, 2020.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Scott Brinks, Diversion Control
Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (571) 362–3261.
SUPPLEMENTARY INFORMATION:
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
SUMMARY:
E:\FR\FM\03JNN1.SGM
03JNN1
]]>Agencies
[Federal Register Volume 85, Number 107 (Wednesday, June 3, 2020)]
[Notices]
[Pages 34237-34238]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11923]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0013]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Extension Without Change of a Previously Approved
Collection; Application for Permit To Import Controlled Substances for
Domestic and/or Scientific Purposes; DEA Form 357
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
[[Page 34238]]
DATES: Comments are encouraged and will be accepted for 60 days until
August 3, 2020.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Scott A. Brinks, Regulatory
Drafting and Policy Support Section, Drug Enforcement Administration;
Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152;
Telephone: (571) 362-3261.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
Overview of This Information Collection
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Application for Permit to Import
Controlled Substances for Domestic and/or Scientific Purposes Pursuant
to 21 U.S.C. 952.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: DEA Form: 357. The applicable
component within the Department of Justice is the Drug Enforcement
Administration, Office of Diversion Control.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): None.
Abstract: Section 1002 of the Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 952) and Title 21, Code of Federal
Regulations (21 CFR), Sections 1312.11, 1312.12 and 1312.13 requires
any person who desires to import controlled substances listed in
schedules I or II, any narcotic substance listed in schedules III or
IV, or any non-narcotic substance in schedule III which the
Administrator has specifically designated by regulation in Sec.
1312.30, or any nonnarcotic substance in schedule IV or V which is also
listed in schedule I or II of the Convention on Psychotropic
Substances, must have an import permit. To obtain the permit to import
controlled substances for domestic and or scientific purposes, an
application for the permit must be made to DEA on DEA Form 357.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: DEA estimates that
171 registrants participate in this information collection, taking an
estimated 0.26 hours per registrant annually.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: DEA estimates the total public burden (in
hours) associated with this collection: 497 annual burden hours.
If additional information is required please contact: Melody
Braswell, Department Clearance Officer, United States Department of
Justice, Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC
20530.
Dated: May 28, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2020-11923 Filed 6-2-20; 8:45 am]
BILLING CODE 4410-09-P
